Researchers identified cathepsin B and L as essential enzymes for Ebola virus reproduction, shedding light on its infection mechanism. Inhibiting these enzymes could lead to the development of a broad-spectrum antiviral therapy against multiple hemorrhagic fever viruses.
Researchers found that 12.9% of wild chimpanzees carry Ebola virus antibodies, indicating regular contact with the animal reservoir and non-fatal infections. Dogs also carry the virus, with high antibody prevalence near epidemic foci, suggesting they could become a potential source of infection for humans.
A new influenza vaccine developed using insect cells can produce a strong immune response in humans and may be scaled up for commercial manufacture. This rapid method uses a purified concentration of hemagglutinin to elicit an immune response against specific flu strains.
Researchers at the Mayo Clinic have successfully created an 'obedient virus' that can specifically target and destroy cancer cells, paving the way for potential use in human therapies. The virus was engineered to seek out cancer cells instead of healthy cells, and has been shown to be effective in laboratory tests.
Researchers have discovered a novel way to block the smallpox virus by targeting a cellular signaling pathway. The approach, which uses an experimental drug called CI-1033, significantly impaired the production of new virus particles and spread of the virus in infected cells.
A new coronavirus has been found in children with symptoms of Kawasaki disease, a condition that also affects the lungs. The virus was detected in 73% of Kawasaki patients but only 5% of healthy children.
A vaccine against cervical cancer has been developed by Dutch researcher Laura Bungener. The vaccine induces an immune response to proteins from human papillomavirus (HPV), rendering it harmless and preventing the growth of tumors. Laboratory animals with existing tumors could also be treated with this vaccination.
Researchers tested a weakened version of herpes simplex virus against neuroblastoma tumors, with only the virus proving effective in treating the cancer. The study shows promise for using the therapy in children and potentially in other cancers as well.
Jefferson scientists discovered that certain parts of the silver-haired bat rabies virus, specifically its glycoprotein cover, enable it to infect the brain rapidly. The researchers found that this type of rabies is capable of evading the immune system more effectively than other strains, making it a key factor in viral pathogenesis.
Researchers discover that adding a single gene from the 1918 virus to a benign strain of influenza can transform it into a highly virulent form. This finding supports the idea that the 1918 Spanish flu virus was inherently more dangerous and provides insight into its transmission among humans.
The study provides new insights into Epstein-Barr virus and its role in autoimmune diseases such as lupus, arthritis, and multiple sclerosis. Researchers found that the virus causes abnormal survival and activation of B cells, leading to excess auto-antibodies.
Researchers found DNA and proteins from BK virus in prostate tissue with abnormal cell changes, a precursor stage of prostate cancer. The virus may induce uncontrolled cell growth, leading to cancer.
The West Nile virus has a devastating impact on small populations of sage-grouse, with a 25% decrease in late summer survival rates. The bird species lacks resistance to the virus, making it essential to improve habitats and implement effective mosquito control measures.
Researchers found six HIV patients who started treatment early became test-negative for the virus. The study suggests that reducing HIV to low levels can help boost the immune system's response to the virus.
Researchers discovered that certain tobacco plant species are resistant to the cowpea mosaic virus. The virus spreads through a plant's vascular system, causing damage and death, but the specific channels it uses to transmit the virus were identified. This knowledge could lead to strategies for creating virus-resistant crops.
Researchers found that RSV can remain dormant in lung tissue for over 100 days after initial symptoms disappear, suggesting a possible link to recurring wheezing and childhood asthma in infected children.
The NIAID-developed DNA vaccine significantly reduced SARS virus levels in infected mice, with antibodies alone responsible for the dramatic reduction. This breakthrough demonstrates the effectiveness of a novel vaccine approach against SARS, paving the way for future human clinical trials.
Researchers at University of Wisconsin-Madison have discovered a potent way to shut down viruses by introducing harmless molecules that mimic the virus's growth machinery, outperforming traditional antiviral strategies in inhibiting viral growth and creating drug-resistant strains.
Researchers found a strong association between monkey virus DNA and non-Hodgkin's lymphoma, suggesting the virus could play a role in its development. The study suggests that targeting the virus could help prevent its development and offers new therapeutic strategies.
A new protein called VLA-1 enables the immune system to develop peripheral immunity by anchoring virus-killing cells to tissues in the lungs. This allows for an instant strike against flu viruses, potentially delivering a better defense against deadly strains like avian flu.
The study found that subtle alterations in the influenza virus's infectivity led to its deadly spread. The researchers determined that a key contributor was the hemagglutinin protein, which allowed the virus to bind to human receptors in an antigenically favorable way.
A study published in Nature Biotechnology found that the Sindbis virus is effective at killing tumors in mice, with varying time and injection schedules required. The virus targets tumor cells by binding to a specific receptor, making it a potential tracking device for cancer.
Researchers analyzed 63 SARS viruses from three phases of the 2002-2003 epidemic and found significant genetic adaptations, including a rapid mutation rate and unique molecular fingerprints. The study suggests that containing outbreaks quickly is crucial before the virus becomes more difficult to control.
The Ebola virus has unleashed several lethal epidemics in Central Africa, leading to haemorrhagic fever and high mortality rates. The virus is transmitted by direct contact with infected animals or their carcasses, resulting in a rapid decline in great ape populations.
Researchers at USAMRIID have developed Ebola virus-like particles (VLPs) that induce both cell-mediated and humoral immunity in mice, providing 100% protection against lethal challenge. The VLPs, resembling infectious viral particles without genetic material, offer a promising vaccine platform for Ebola and other viruses.
Researchers found a physical interaction between herpes virus and amyloid precursor protein (APP), suggesting a potential clue to Alzheimer's disease. The discovery may lead to further investigations into the role of the virus in the disease.
Purdue University biologists have determined the structure of the West Nile virus, a development that could greatly augment our understanding of the virus' life cycle. The research uses cryoelectron microscopy and advanced imaging techniques to understand how the major surface proteins interact with each other.
Rao's research aims to understand the mechanism of virus assembly, a crucial step in viral transmission and disease spread. By studying the brome mosaic virus, his lab hopes to develop new strategies for blocking virus assembly and preventing disease.
A live but weakened virus is being tested as a potential West Nile virus vaccine, with promising results showing high levels of protective antibodies in monkeys. The vaccine has been shown to be effective in preventing the disease-causing virus while triggering a strong immune response.
The Mayo Clinic Proceedings has released an early review of West Nile virus to aid clinicians and the public. The review, written by Priya Sampathkumar, M.D., provides the most current information on the disease's epidemiology, virology, transmission, management, and prevention in humans and animals.
Researchers have developed a new herpes-based AIDS vaccine that could help the immune system produce more infection-fighting antibodies and killer T-cells, potentially making it more effective. The vaccine uses an amplicon to deliver DNA from the AIDS virus, which is then amplified and used to trigger an immune response.
A research team led by Nathaniel Landau identified the interaction between HIV's Vif protein and APOBEC3G. The study found that mice have a similar antiviral protein that can block HIV replication due to its inability to recognize human proteins.
Researchers at Purdue University have obtained the first-ever images of a developing dengue virus, revealing a complex developmental process that could lead to the discovery of new antiviral medicines. The immature particle is covered with protein spikes that flatten out as it matures into the infectious dengue virus.
Researchers discovered that 29% of individuals were completely resistant to the Norwalk virus, with those lacking the FUT2 gene showing no signs of infection. The study suggests that vaccination may be effective in reducing disease burden and offers new hope for developing vaccines.
Researchers discovered that a new class of protease inhibitors can prevent the hepatitis C virus from blocking the innate immune response, restoring it in human cells. This finding suggests that these drugs will have dual efficacy and could become an important addition to existing treatments for hepatitis C.
A mathematical model developed by Don Klinkenberg suggests that partial vaccinations can effectively control the spread of swine fever. The model indicates that vaccination reduces the spread of the virus but does not completely prevent it, allowing for epidemic persistence for several months.
The St. Jude team successfully developed a custom-made vaccine against the H5N1 flu virus in just four weeks, thanks to a modified technique called reverse genetics. The vaccine was created by mixing genes from H5N1 with those from a common flu virus, making it safe for human use.
Researchers found West Nile virus can cause muscle weakness, acute paralysis, and impaired breathing, leading to life-threatening symptoms. Four Mississippi patients who died after developing West Nile virus were examined and showed signs of viral infection in spinal cord autopsies.
Researchers discovered that the removal of MTase1, a viral protein, did not impact virus replication rates in tissue culture. This finding suggests that proteins essential to virus function may be more complex than previously thought, with implications for understanding virus behavior and potential applications in pest control.
HIV-1 uses a unique 'glycan shield' mechanism to evade antibody attack, continuously changing large sugar molecules on its surface. This allows the virus to outsmart the immune system and escape elimination.
Researchers found that HIV patients develop strong antibody responses against the virus, but these antibodies fail to keep pace with the virus's constant mutation process. This study sheds light on the complex dynamics between the immune system and HIV, highlighting potential avenues for vaccine development.
Researchers at St. Jude Children's Research Hospital found that an anti-flu-virus drug can protect against pneumonia by blocking the activity of flu virus enzyme neuraminidase. This protection reduces illness and incidence of death from subsequent infection by Streptococcus pneumoniae bacteria.
Scientists at Imperial College London have discovered a unique method of viral transmission by the HTLV-1 leukaemia virus. The virus infects cells and transfers itself to other cells without releasing particles, evading the immune system and paving the way for potential new treatments.
Researchers found that B cells and antibodies are essential for controlling the infection in mice. Without them, even low doses of the virus can be deadly. The study's findings may explain why elderly people and those with weakened immunity are more likely to develop serious disease.
Researchers uncover molecular signal critical for selective recruitment of viral RNA segments to form complete flu genome. This discovery may help develop new vaccines and antiviral drugs targeting the genetic trick used by the flu virus.
Researchers at the University of Pennsylvania School found that the West Nile virus capsid protein can cause inflammation and apoptosis in cells, leading to encephalitic inflammation. The study suggests that blocking the protein's pathogenicity may help slow down the virus.
A team of scientists has developed a laboratory system to study the virus in its latent stage, discovering genes that may give it stealth capabilities. This could lead to the development of new drugs to clear the virus from infected individuals.
Researchers at Temple University have discovered a possible link between the common human virus JC virus and colon cancer. The study found that the viral genome and proteins were present in malignant epithelial tumors in the large intestine, which may play a role in tumor development.
Researchers have identified three new genes in a rhesus monkey rhadinovirus with high structural similarity to those in human herpesvirus-8, paving the way for future studies using recombinant viruses. The goal is to develop targeted drug therapies against specific KSHV genes to prevent virus spread and cancer induction.
Researchers at Hebrew University have developed a novel technique that uses an engineered virus to induce cancer cells to activate PKR protein, causing them to self-destruct. This innovative approach has shown promising results in halting the spread of brain tumors and offers a new direction for cancer treatment.
Scientists found that herpes virus uses regulators of complement activation (RCA) to evade the immune system. The study reveals that complement plays a crucial role in controlling persistent and latent infection, contradicting previous assumptions.
A team of Los Alamos researchers suggests using a consensus sequence of the HIV-1 virus as a basis for vaccines, rather than geographically specific strains. This approach aims to target common vulnerabilities in multiple strains of the virus.
A study published in JAMA found that nearly 28% of newly infected people have a strain of HIV resistant to at least one class of antiretroviral drugs, highlighting the need for new treatment options. The research also shows that drug-resistant viruses take longer to control with current treatments.
Researchers at Stanford University Medical Center have developed a novel approach to fighting cancer using a modified cold virus that targets cancer cells while leaving normal cells unharmed. In a phase I study, 28 patients who received the highest dose of the virus survived for nearly a year and saw significant tumor shrinkage.
Researchers have developed a hybrid vaccine that protects mice from West Nile virus infection by combining weakened dengue and West Nile viruses. The vaccine stimulates strong immune responses and has shown to be effective in mice, paving the way for human trials.
The study reveals how the T4 virus binds to host cells, punctures the cell wall, and injects its genetic blueprint into the cell. The research provides detailed information on the virus structure and mechanisms used by one virus often resemble those of other viruses, including those that infect humans.
Researchers have successfully attached molecules to the surface of a virus, creating a novel method for immobilizing large molecules on viral surfaces. This technique has potential applications in nanotechnology, materials science, and medicine.
Researchers identified a genetic anomaly in mice resistant to the ecotropic murine leukemia virus, a major cancer-causing virus. By analyzing proteins, they found a defective protein that blocks viral entry, potentially leading to new gene therapies for humans.
Researchers have found a new, hidden piece of the influenza virus that may kill immune system cells. This protein was discovered by accident while studying
A new study reveals that HIV-specific CD4+ T cells persist in infected individuals, but high virus levels suppress their proliferative response. The research provides clues on how the virus manipulates the immune system for its own survival and challenges the notion of long-term nonprogressors.